EUVIMEDEUVIMED entdecken
Crossref

Piperazin incorporated Schiff Base derivatives: Assessment of in vitro biological activities, metabolic enzyme inhibition properties, and molecular docking calculations

Arif Mermer, Burak Tüzün, Sevgi Durna Daştan, Ümit M Koçyiğit, Feyza Nur Çetin, Özge Çevik

Journal of Biochemical and Molecular Toxicology · 2023-11 · 37 (11)

DOI: 10.1002/jbt.23465 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, online erschienen am 18.07.2023. Verfasst von Arif Mermer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Medicine Application & Research Center, Validebağ Research Park, University of Health Sciences, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 61 Literaturangaben. Gefördert von: Scientific Research Project Fund of Sivas Cumhuriyet University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cytotoxic activities of the compounds were determined by the 3‐(4,5‐dimethylthiazolyl‐2)‐2,5‐diphenyltetrazolium bromide (MTT) method in human breast cancer (MCF‐7), human cervical cancer (HeLa), and mouse fibroblast (L929) cell lines. The compounds MAAS‐5 and four modified the supercoiled tertiary structure of pBR322 plasmid DNA. MAAS‐5 showed the highest cytotoxic activity in HeLa, MCF‐7, and L929 cells with IC50 values of 16.76 ± 3.22, 28.83 ± 5.61, and 2.18 ± 1.22 µM, respectively. MAAS‐3 was found to have almost the lowest cytotoxic activities with the IC50 values of 93.17 ± 9.28, 181.07 ± 11.54, and 16.86 ± 6.42 µM in HeLa, MCF‐7, and L929 cells respectively at 24 h. Moreover, the antiepileptic potentials of these compounds were investigated in this study. To this end, the effect of newly synthesized Schiff base derivatives on the enzyme activities of carbonic anhydrase I and II isozymes (human carbonic anhydrase [hCA] I and hCA II) was evaluated spectrophotometrically. The target compounds demonstrated high inhibitory activities compared with standard inhibitors with K i values in the range of 4.54 ± 0.86–15.46 ± 8.65 nM for hCA I (K i value for standard inhibitor = 12.08 ± 2.00 nM), 1.09 ± 0.32–29.94 ± 0.82 nM for hCA II (K i value for standard inhibitor = 18.22 ± 4.90 nM). Finally, the activities of the compounds were compared with the Gaussian programme in the B3lyp, HF, M062X base sets with 6‐31++G (d,p) levels. In addition, the activities of five compounds against various breast cancer proteins and hCA I and II were compared with molecular docking calculations. Also, absorption, distribution, metabolism, excretion, and toxicity analysis was performed to investigate the possibility of using five compounds as drug candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBreast NeoplasmsMiceAnimalsHumansFemaleMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipCarbonic Anhydrase InhibitorsSchiff BasesCarbonic Anhydrase I

Stichwörter der Autor:innen

Enzyme InhibitionSchiff basecell culturedensity functional theorymolecular docking

Substanzen

Carbonic Anhydrase InhibitorsSchiff BasesCarbonic Anhydrase IAntineoplastic Agents

Autor:innen und Institutionen

  • Experimental Medicine Application & Research Center, Validebağ Research Park, University of Health Sciences, Istanbul, Türkiye.
  • Department of Biotechnology, University of Health Sciences, Istanbul, Türkiye.
  • Plant and Animal Production Department, Technical Sciences Vocational School of Sivas, Sivas Cumhuriyet University, Sivas, Turkey.
  • Department of Biology, Faculty of Science, Sivas Cumhuriyet University, Sivas, Turkey.
  • Department of Basic Pharmaceutical Sciences, Sivas Cumhuriyet University, Sivas, Turkey.
  • Department of Biochemistry, Adnan Menderes University, Aydın, Turkey.

Förderung

  • Scientific Research Project Fund of Sivas Cumhuriyet University

Zitieren

APA

Mermer, A., Tüzün, B., Daştan, S. D., Koçyiğit, Ü. M., Çetin, F. N., & Çevik, Ö. (2023). Piperazin incorporated Schiff Base derivatives: Assessment of in vitro biological activities, metabolic enzyme inhibition properties, and molecular docking calculations. Journal of Biochemical and Molecular Toxicology, 37(11). https://doi.org/10.1002/jbt.23465

Vancouver

Mermer A, Tüzün B, Daştan SD, Koçyiğit ÜM, Çetin FN, Çevik Ö. Piperazin incorporated Schiff Base derivatives: Assessment of in vitro biological activities, metabolic enzyme inhibition properties, and molecular docking calculations. Journal of Biochemical and Molecular Toxicology. 2023;37(11). doi:10.1002/jbt.23465

BibTeX
@article{Mermer2023,
  author = {Mermer, Arif and Tüzün, Burak and Daştan, Sevgi Durna and Koçyiğit, Ümit M and Çetin, Feyza Nur and Çevik, Özge},
  title = {Piperazin incorporated Schiff Base derivatives: Assessment of in vitro biological activities, metabolic enzyme inhibition properties, and molecular docking calculations},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2023},
  volume = {37},
  number = {11},
  doi = {10.1002/jbt.23465}
}
Kostenlos starten →